Abbott India bulk deals and stake changes
NSE: ABBOTINDIABSE: 500488Pharmaceuticals & BiotechnologyMid Cap
Share price at the NSE close on 27 Oct 2026. Previous close ₹25,225.00.
27 Oct: open ₹25,490.00, high ₹25,580.00, low ₹25,215.00
- Next results date: the board meets on 5 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹54,218 Cr183rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 33.58
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 11.36
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.57%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 35.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 39.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,73057.6% delivered
Abbott India stake sales and purchases
All 3 disclosures on record.
Mar 2017
- SoldReliance Capital Trustee Co Ltd0.47% of the company1,00,000 sharesholds 3.31% after1 Mar 2017 · filed under the 2% rule · Market
- SoldReliance Capital Trustee Co Ltd A/c through various schemes of Reliance Mutual Fund0.47% of the company1,00,000 sharesholds 3.31% after1 Mar 2017 · filed under the 2% rule · Open Market
May 2011
- AcquiredReliance Equity Opportunities Fund & Reliance Pharma Fund Shcemes of Reliance Mutual Fund1.46% of the company1,99,721 sharesholds 5.74% after17 May 2011 · filed under the 1997 takeover rules · Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Abbott India bulk deals
None in the last 12 months, since 28 Oct 2025.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Tuesday 17 May 20112 firms · ₹29 Cr bought · ₹32 Cr soldNet sold ₹3.55 Cr
- SoldABBOTT CAPITAL INDIA LIMITEDSold 2,24,000 at ₹1,437.93₹32 Cr
- BoughtRELIANCE MUTUAL FUND (SCHEME : RELIANCE CAPITAL TRUSTEE CO.Bought 1,99,441 at ₹1,437.00₹29 Cr
Wednesday 30 Sep 20091 firm · ₹5.77 Cr bought · ₹0 soldNet bought ₹5.77 Cr
- BoughtARION COMMERCIAL PVT LTDBought 79,203 at ₹728.35₹5.77 Cr
Friday 29 Jun 20072 firms · ₹15 Cr bought · ₹16 Cr soldNet sold ₹0.31 Cr
- SoldHDFC TRUSTEE CO LTD A C HDFC LONG TERM EQUITY FUNDSold 3,05,807 at ₹510.13₹16 Cr
- BoughtRELIANCE CAPITAL TRUSTEE CO LTD A C RELIANCE LONG TERM EQUITBought 2,99,750 at ₹510.00₹15 Cr
A bulk deal is one client trading more than half a per cent of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 5 deals on record from 4 Jan 2004.